SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-19-001120
Filing Date
2019-01-14
Accepted
2019-01-14 16:05:25
Documents
1
Period of Report
2018-11-16

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 14166
  Complete submission text file 0000899243-19-001120.txt   15722
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Issuer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 333 TWIN DOLPHIN DRIVE SUITE 600 REDWOOD CITY CA 94065
Business Address
Vexler Vladimir (Reporting) CIK: 0001759506 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-36721 | Film No.: 19525127